Search results
Morton J Kern
Research Area(s) / Expertise:
Job title: Professor
Author
Author(s):
Martin S Maron
Added:
2 years ago
In this video, Dr Martin Maron (Tufts Medical Center, Boston, MA, US) discusses the findings of Redwood-HCM, a phase 2 dose-escalation clinical trial evaluating the effect of second-gen drug aficamten in the treatment of patients with obstructive hypertrophic cardiomyopathy (HCM). This research was originally presented at HFSA 2021. Results indicate aficamten was well tolerated and resulted in…
View more
Andrew Higgins
Job title: Clinical Cardiologist & Associate Director of Cardiac ICU
Author
Qiong (Joan) Zhao
Research Area(s) / Expertise:
Job title: Medical Director
Author
Matthew E Li Kam Wa
Author
Akshay S Desai
Research Area(s) / Expertise:
Author
Author(s):
Sebastiaan HC Klaassen
,
Dirk J van Veldhuisen
,
Hans LA Nienhuis
,
et al
Added:
3 years ago
Heart failure with a preserved ejection fraction (HFpEF) comprises half of the heart failure population, and is associated with high morbidity and mortality. HFpEF is induced by multiple coexisting comorbidities, mostly of non-cardiac origin, leading to increased stiffness of the myocardial wall, diastolic dysfunction, elevated filling pressures and eventually to heart failure.1 The interplay…
View more
Anjali T Owens
Research Area(s) / Expertise:
Job title: Associate Professor of Medicine
Author
Author(s):
Angela Hoye
,
Rodney H Stables
,
Anthony Mathur
,
et al
Added:
1 year ago
BCIS ACI 2023 – Dr Angela Hoye (Hull & East Yorkshire Hospitals, UK), is joined by Dr Rod Stables (Liverpool Heart and Chest Hospital, UK), Dr Anthony Mathur (Barts Health NHS Trust, UK) and Dr Sen Devadathan (Royal Cornwall Hospitals NHS Trust, UK) to have a critical discussion on the BCIS-REVIVED trial and what it means for patients with ischemic left ventricular dysfunction in 2023.
Data…
View more
Bernard J Gersh
Job title: Professor of Medicine
Author